CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Induction chemotherapy with FOLFIRINOX in pancreatic cancer and then? Experience with a novel scheme of maintenance, treatment pause and re-induction
DOI 10.1055/s-0036-1587270
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Hann, W Bohle, WG Zoller
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Chemotherapy regimens for locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC) have changed since the introduction of FOLFIRINOX (5-fluoruracil (5FU/LV), Oxaliplatin, Irinotecan and Leucovorin) which confer a significant survival benefit compared to gemcitabine-based monotherapy. Increased toxicity, mainly sensory peripheral neuropathy, limits its use and the number of applied chemoth…
Zitieren
Zitierempfehlung
A Hann, W Bohle, WG Zoller (2016) Induction chemotherapy with FOLFIRINOX in pancreatic cancer and then? Experience with a novel scheme of maintenance, treatment pause and re-induction. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0036-1587270
Mit CareLit weiterarbeiten